Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-01 1:09 pm Sale | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | FRANKLIN RESOURCES INC BEN | 2,838,135 4.900% | -429,812 (-13.15%) | Filing History |
| 2023-01-23 4:31 pm Sale | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | MILLENNIUM MANAGEMENT LLC | 1,369,021 2.400% | -1,053,652 (-43.49%) | Filing History |
| 2022-07-08 4:19 pm Purchase | 2022-07-01 | 13G | Sutro Biopharma, Inc. STRO | MILLENNIUM MANAGEMENT LLC | 2,422,673 5.200% | 2,422,673 (New Position) | Filing History |
| 2022-02-14 12:00 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | Eventide Asset Management, LLC | 2,708,975 5.900% | 338,000 (+14.26%) | Filing History |
| 2022-02-11 4:49 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 2,473,795 5.400% | 65,400 (+2.72%) | Filing History |
| 2022-02-04 1:45 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | FRANKLIN RESOURCES INC BEN | 3,267,947 7.100% | 3,267,947 (New Position) | Filing History |
| 2022-02-02 7:18 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 3,700,043 8.000% | 982,114 (+36.13%) | Filing History |
| 2022-01-18 5:18 pm Purchase | 2022-01-07 | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 3,160,416 6.800% | 1,306,254 (+70.45%) | Filing History |
| 2021-12-10 4:31 pm Purchase | 2021-11-30 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 2,408,395 5.200% | 2,408,395 (New Position) | Filing History |
| 2021-04-05 5:28 pm Purchase | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | BRISTOL MYERS SQUIBB CO BMY | 1,726,197 3.800% | 1,726,197 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | CITADEL ADVISORS LLC | 1,301,804 2.900% | -427,172 (-24.71%) | Filing History |
| 2021-02-16 4:22 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | Ridgeback Capital Investments L.P. | 1,144,979 2.500% | -869,708 (-43.17%) | Filing History |
| 2021-02-16 08:57 am Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | Alta Partners VIII L.P. | 0 0.000% | -1,948,516 (Position Closed) | Filing History |
| 2021-02-12 5:23 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | EcoR1 Capital LLC | 93,416 0.200% | -2,235,076 (-95.99%) | Filing History |
| 2021-02-12 4:25 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 1,854,162 4.100% | -514,230 (-21.71%) | Filing History |
| 2021-02-12 4:10 pm Purchase | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | Eventide Asset Management, LLC | 2,370,975 5.300% | 1,126,080 (+90.46%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 2,717,929 6.200% | 2,717,929 (New Position) | Filing History |
| 2020-08-28 4:06 pm Purchase | 2020-08-19 | 13G | Sutro Biopharma, Inc. STRO | EcoR1 Capital LLC | 2,328,492 6.500% | 2,328,492 (New Position) | Filing History |
| 2020-08-24 6:54 pm Purchase | 2020-08-13 | 13G | Sutro Biopharma, Inc. STRO | Ridgeback Capital Investments L.P. | 2,014,687 5.300% | 2,014,687 (New Position) | Filing History |
| 2020-05-22 5:22 pm Purchase | 2020-05-12 | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 2,368,392 6.600% | 2,368,392 (New Position) | Filing History |